'Tb incidence' presentation slideshows

OVERVIEW SLIDES

Stop TB Working Group on New Vaccines: Task Force on Economics and Product Profiles Discussion Points London School of Hygiene and Tropical Medicine 11-12 December 2008. Andrew Farlow Research Fellow in Economics, Oriel College www.economics.ox.ac.uk/members/andrew.farlow. OVERVIEW SLIDES.

894 views • 78 slides

OVERVIEW SLIDES

Stop TB Working Group on New Vaccines: Task Force on Economics and Product Profiles Discussion Points London School of Hygiene and Tropical Medicine 11-12 December 2008. Andrew Farlow Research Fellow in Economics, Oriel College www.economics.ox.ac.uk/members/andrew.farlow. OVERVIEW SLIDES.

887 views • 78 slides

TB Vaccines Development

TB Vaccines Development. ASEAN-EU STI Cooperation Meeting Thailand Science Park, Thailand 21 -23 January 2014. JAIME C. MONTOYA, MD, MSc, PhD Coordinator, ASEAN-NDI Secretariat Focal Point for the Philippines, ASEAN Subcommittee on Biotechnology

847 views • 58 slides

Tuberculosis in Prisons & Jails:

Tuberculosis in Prisons & Jails:. Public Health Challenges and Opportunities. Prevention & Control of Tuberculosis in Prisons & Jails. Observation #1. Correctional facilities are high incidence TB settings with a high risk for TB transmission. .

805 views • 48 slides

Steffanie A. Strathdee, Ph.D. Associate Dean of Global Health Sciences, Harold Simon Professor;

Steffanie A. Strathdee, Ph.D. Associate Dean of Global Health Sciences, Harold Simon Professor; Chief, Division of Global Public Health, Department of Medicine, University of California, San Diego sstrathdee@ucsd.edu.

572 views • 46 slides

WHY A SUCCESSFUL TB CONTROL DOES NOT DECREASE DISEASE INCIDENCE?

493 views • 40 slides

641 views • 39 slides

TB-HIV INTEGRATION IN THE WORKPLACE

TB-HIV INTEGRATION IN THE WORKPLACE. 2 nd Private Sector Conference on HIV and AIDS Presenter: Dr S Charalambous. Presentation outline. TB burden in HIV-infected individuals WHO TB-HIV collaborative activities 3 Is strategy: Intensive case finding INH preventive therapy Infection control

469 views • 34 slides

Using Prognostic B iomarkers to Target TB Preventive T herapy

Using Prognostic B iomarkers to Target TB Preventive T herapy IDM 5th Annual Disease Modeling Symposium Seattle 2017 Mark Hatherill South African Tuberculosis Vaccine Initiative (SATVI) University of Cape Town, South Africa. The global TB epidemic has peaked

448 views • 32 slides

Indirect estimation of burden in TB epidemiology

Indirect estimation of burden in TB epidemiology. Chris Dye, coordinator of STB/TME. 5 targets for global TB control MILLENNIUM DEVELOPMENT GOALS "to have halted and begun to reverse incidence..". Implementation (DOTS) Indicator 24 (target year 2005) Case detection 70% (> 6 m diagnosed)

418 views • 29 slides

W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S Tuberculosis Consultant

393 views • 25 slides

Isoniazid preventive therapy in a time of HIV, TB, and MDR

Isoniazid preventive therapy in a time of HIV, TB, and MDR. Why do TB and HIV programs and the HIV community itself ignore IPT?. WHO Recommended Policy on Collaborative TB/HIV Activities

371 views • 25 slides

TB epidemiology in Thailand

TB epidemiology in Thailand. Philippe Glaziou, on behalf of the epi team Bangkok, August 2013. TB in Thailand: key figures (2012). 80,000 new cases 11,000 TB deaths. Thailand among 22 countries with highest TB incidence. TB epidemiology: case notification rate. All forms. Smear pos.

357 views • 20 slides

Suzanne Verver, epidemiologist

Determine TB prevalence and incidence, select trial sites and choose target populations for TB vaccines. Suzanne Verver, epidemiologist. 3 rd Global Forum on TB vaccines, 26 March 2013, Cape Town. Outline. Choose target populations Epi studies to determine TB prevalence and incidence

301 views • 19 slides

264 views • 18 slides

287 views • 18 slides

284 views • 16 slides

THRio Objectives

Impact of tuberculosis screening and isoniazid preventive therapy on incidence of TB and death in the TB/HIV in Rio de Janeiro (THRio) study. B. Durovni 1,2 , V. Saraceni 1 , A. Pacheco 3 , S. Cavalcante 1,3 , S. Cohn 4 , B. King 4 , L. Moulton 4 , R. Chaisson 4 , J. Golub 4 , THRio study group

243 views • 14 slides

Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program

Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program. Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA. Lesotho. Population: 1.8 million TB incidence is estimated at 640/100,0000 3 rd Highest HIV prevalence (23.6%) 78% of the TB patients are HIV infected.

285 views • 12 slides

Millennium Development Goals (MDGs) and Role of Media

Millennium Development Goals (MDGs) and Role of Media . Minar Pimple Regional Director, Asia and the Pacific UN Millennium Campaign. Accountability Framework of the MDGs.

339 views • 9 slides